Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (CTNG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00973466|
Recruitment Status : Completed
First Posted : September 9, 2009
Last Update Posted : January 13, 2011
There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health.
Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.
|Condition or disease|
|HIV Infections Neisseria Gonorrhoeae Chlamydia Trachomatis Herpes Simplex|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Prevalence of Asymptomatic and Symptomatic Infection of N. Gonorrheae and C. Trachomatis and Seroprevalence of HSV Typ 2 and Sexual Health Seeking Behaviour in People With HIV Infection in Bern|
|Study Start Date :||May 2009|
|Actual Primary Completion Date :||May 2010|
|Actual Study Completion Date :||June 2010|
All HIV-infected patients attending the Clinic for Infectious Diseases at Berne university hospital, having been sexually active during the past 12 months and having given written informed consent
- Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection [ Time Frame: 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00973466
|Clinic for Infectious Diseases, Berne University Hospital|
|Bern, Switzerland, 3010|
|Principal Investigator:||Hansjakob Furrer, MD||University Hospital Berne|